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Abstract 
Introduction: Diabetes mellitus in Malta has been 
an established major health problem for years. It has 
been linked with cultural, geographical, historical, 
genetic as well and a change from a Mediterranean diet 
to a Westernized diet. This diabetes burden has lead to 
establishment of diabetes clinics both in the central 
general hospital, as well as in the community. Over the 
past 50 years, there have been two major 
epidemiological diabetes studies conducted to evaluate 
diabetes in the Maltese population.  
Diabetes in Malta: To date, there is no established 
national diabetes plan or diabetes register in Malta, 
although there has been the formation of a governmental 
diabetes focus group. The time is right for an updated 
prevalence study to look at the current Maltese 
generation and their changing determinants including 
diabetes risk factors and genetics, followed by the 
development of preventative strategies and policies.  
Conclusion: Over the years, diabetes burden has 
increased and become a public health and national 
financial concern. It is of utmost importance to address 
this national disease. An updated prevalence study 
would provide the evidence-based backbone for the 
development of diabetes preventive strategies and 
policies. The combination of which will enable the 
Maltese health services to be improved and better 
equipped to come to grips with this epidemic. 
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Introduction 
Diabetes mellitus type 2 (T2DM) is a growing 
epidemic globally.  By 2013 it was affecting 382 million 
people worldwide with an estimated 135 million 
currently unaware of their disease status.1 Those 
suffering from T2DM are known to have a significant 
reduction in life quality as well as life expectancy, 
directly caused by this disease.2 Moreover, in 2013 
diabetes was estimated to be responsible for 5.1 million 
deaths worldwide.1  
As in other European countries, diabetes mellitus is 
a major health problem in the Mediterranean island of 
Malta. T2DM is not a recent occurrence in Malta and it 
is known that by the eighteenth century, diabetes was 
already documented in medical literature. 3 Diabetes has 
been documented to have a negative impact on the lives 
of many Maltese since 1886, where diabetes was noted 
to be responsible for 2.1 per 10,000 deaths of the 
population. Diabetes related mortality rate continued to 
increase to 4.5 per 10,000 of population in 1900 and 8.7 
per 10,000 in 1942. By 1955, Malta had the leading 
recorded diabetes mortality rate in the world with 26.1 
deaths per 100,000 population followed by Belgium 
with 23.9, the USA with 15.5 and Italy with 11.1. 4 
The scope of the present paper is to review diabetes 
mellitus type 2 in Malta over the years along with the 
various local factors contributing to the high prevalence 
of diabetes in Malta and the current diabetic 
epidemiological situation.  
Predisposing factors for Diabetes Mellitus in Malta 
Malta is a small island in the center of the 
Mediterranean Sea, positioned at the crossroads between 
Europe and North Africa. Over the years, Malta 
sustained different cultural changes as one dominating 
empire took over from another, leaving an ethnic 
mixture, substantial socio-diversity and varied genetic 
imprints on the Maltese population. 5 In 2008, as part of 
his PhD studies Al-Ashtar A. reports that both the 
Maltese and the Libyan populations had similar genetic 
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diabetic and metabolic profiles. 6 In a recent PhD study, 
Pace N. found as many as ten candidate genes 
significantly associated with type 2 diabetes mellitus and 
the metabolic syndrome among adult Maltese newly 
diagnosed diabetic persons. 7 In Malta, a strong family 
history of diabetes among Diabetics was already 
established with a statistical significant relationship 
between Diabetes and both maternal and paternal 
diabetes history.8-9  
Having a restricted irrigated agricultural land has 
meant that Malta had to import most of its food supplies 
from overseas. The dependence on imports and their 
inconsistent supply had led to a tendency for chronic 
food deprivation in years gone by, especially during the 
period of world war II (1937 – 1949) affecting all of the 
population including pregnant women and their unborn 
children. 10 This most probably led to the development of 
the Thrifty Diet Phenotype. This phenotype is a 
protective mechanism developed to adapt for periods of 
starvation and food deprivation.11  
It was suggested that a strong link between Malta 
and Diabetes contributed to a change from a 
Mediterranean diet to a more British type of diet in the 
late 19th to early 20th century, which may have led to this 
increase in T2DM prevalence. The theory suggests that 
an increased intake of fat and refined carbohydrates led 
to an overload of the Thrifty Diet Physiology which is in 
turn responsible for the increase in peripheral insulin 
resistance as well as to an increase in the prevalence of 
obesity.3 This forms the Baker’s hypothesis whereby 
those children originally adapted to surviving in a 
starved situation, now faced rich foods predisposing 
towards childhood and adulthood obesity and adult 
T2DM.12 This link was found to be present in the 
Maltese population when the 2001-02 Health Behaviour 
in School children Study (HSBC) showed that 33.3% of 
the Maltese population was either overweight or obese.13  
In more recent times, pregnant women in Malta 
have been found to be overfeeding their unborn child 
while in utero. This predisposes the child to foetal 
obesity or macrosomia. This is the basis of the 
Pedersen’s hypothesis, which suggests that such a 
situation leads to the foetal pancreas and hypothalamus 
being adapted to this nutritional state with a 
predisposition to obesity and T2DM later on in their 
lives.14 
Past epidemiological studies in Malta 
A high diabetes occurrence in the Maltese 
population was first documented in 1927, and in his 
book, Debono JE. describes the prevalence estimated to 
be 4.5% of the population and the disease firmly linked 
with obesity.15  
The increasing disease burden over the years led to 
the establishment of a special Diabetes Clinic in 1939 at 
the only general hospital in the island. By the 1950s,  
T2DM was considered to be of major public health 
concern, during which time there was an extension of 
diabetic clinics in the community.3, 16 This heightened 
the keen interest of local academia and by 1964, the first 
epidemiological diabetes ‘pilot study’ was conducted by 
Prof. J. Zammit Maemple. Table 1. Summaries the study 
design, results and outcomes of this study.17  
 
Table 1: Summaries the first epidemiological study 
(1964) design and outcome 
T2DM – Type 2 Diabetes Mellitus; DM – Diabetes Mellitus; 
OGTT – Oral Glucose Tolerance Test 
 
  JV Zammit Maempel - 1964 
   
Population 
Sample 
 5757 subjects 
Population 
demographics 
 All ages 
Study Design  All households in Urban area of 
Floriana & Rurar area of 
Gharghur, Madliena and Bahar 
ic-Caghaq 
Screening 
methods 
  
 Phase I Urine dipstick for glucose, 
reducing substance, ketone 
bodies & albumin 
 Phase II Glycosurics (from phase I) 
undergone a 50g OGTT, 
questionnaire and physical 
examination, along with an 
equal number of age-matched 
non-glycosuria individuals 
 Phase III Statistical Study of the findings 
   
Results Phase I Glycosuria - 8.9% (9% males; 
8.8% females); Albuminuria - 
23% 
 Phase II Of the glycosuric - 70.1% had 
DM; 7.4% lag storage curve; 
7.4% had renal glycosuria; 
remaining had normal OGTT. 
  Of the non-glycosurics - 15% 
had DM, 15.7% lag storage 
curve; 1.5% had renal 
glycosuria; 67.8% had normal 
OGTT 
Risk factors  Obesity (60 out of 100 
diabetics) 
Complications  Peripheral Vascular disease, 
Coronary disease, 
Cerebrovascular disease, 
Hypertension 
T2DM 
prevalence 
 19.9% 
Newly 
Diagnosed 
T2DM 
 1 out of every 10 inhabitants 
28
  
 
 
 
Original Article  
 
 
Malta Medical Journal    Volume 26 Issue 03 2014                                                                                                                
 
 
In 1981, the World Health Organization (WHO) 
performed the second prevalence study on Diabetes in 
Malta. During the same year, the Maltese Diabetes 
Association was set up and a year later (1982) became 
part of the International Diabetes Federation (IDF).  
Table 2. Summaries the study design, results and 
outcomes of this study.18 
 
Table 2: Summaries the 1981 WHO epidemiological 
study design and outcomes 
T2DM – Type 2 Diabetes Mellitus; DM – Diabetes Mellitus; 
OGTT – Oral Glucose Tolerance Test; IGT- Impaired 
Glucose Tolerance; MI- Myocardial Infarction. 
 
 
The pilot study conducted by Prof. Zammit 
Maempel in 1964 could today be critically appraised for 
its design, whereby the sample population studied was 
non-randomized and not a representative sample of the 
Maltese population. There was no stratification for the 
different social factors and age, making it more difficult 
to differentiate the different types of diabetes. One can 
appreciate however, that as a first attempt to establish 
diabetes prevalence, it gave a clear idea of the relatively 
high diabetes burden among the Maltese population and 
of the poor control of the disease among sufferers at the 
time as well as of the strong local link of the disease 
with obesity.  
The measurement tools used comprising seeking 
out glycosuria and subsequently confirming with an oral 
glucose tolerance test (OGTT) was also quite unique.  
When considering the study conducted by WHO in 
1981, one appreciates the improved epidemiological 
approach and the use of a randomized stratified sample 
of the population selected from the electoral list.  
The screening method used by the WHO was the 
75g OGTT - the gold standard screening tool, unlike the 
50g OGTT used in the Zammit Maempel study earlier. 
The WHO study gave a more reliable and comparable 
diabetes profile, with appropriate distribution by age and 
gender. 
No further population based studies have since 
elaborated on the changing Diabetes picture and burden 
in Malta until 2010, when the local centre of the 
European Health Examination Survey pilot study 
examined 400 randomized adult participants (18+ years) 
and, on the basis this time of a fasting glucose level, 
obtained a diabetes prevalence of 9.8% for this 
population. Females (10.7%) had a higher blood glucose 
average as compared to males (9%). This study, in 
common with the previous 2 studies, reported that those 
already diagnosed with diabetes had a generally poor 
diabetic management; with 38.5% of the known 
diabetics having an elevated blood glucose level.19 This 
study utilised a relatively small population sample size 
and consequently, results exhibited wide confidence 
intervals.  The results must therefore be considered with 
caution. 
During the same year, the Department of Health 
Promotion and Disease Prevention issued “A Strategy 
for the Prevention and Control of Non-communicable 
Disease in Malta”, which recommended local diabetes 
targets for 2020. 20  
 
Diabetes burden in Malta - Nowadays 
To date, there is no national diabetes plan or 
diabetes register in Malta. Similarly, there is a lack of 
established preventative or screening protocols for 
diabetes.  The lack of any updated diabetes prevalence 
data for the Maltese population is a clear hindrance to 
the formulation of any such plans and protocols.  
  World Health Organization 
Study - 1981 
   
Population 
Sample 
 2945 subjects 
Population 
demographics 
 > 15 years 
Study Design  Randomized from electoral list, 
stratified according to age, 
gender, occupation & education 
   
Screening 
methods 
 If not previously diagnosed with 
DM: 
 Phase I Fasting blood capillary sample 
from ear lobe, Fasting urine 
sample (glucose, proteins, blood 
& ketones), 75g OGTT, 
questionnaire, blood pressure, 
weight, height, and skinfold 
thickness. 
 Phase II Repeat of OGTT in those with 
abnormal or indeterminate result 
in phase I. Blood for Insulin, C-
peptide, HLA-type, blood 
groups, Renal profile, Uric acid, 
lipid profile, 
 Phase III Clinical follow up of 
complications 
   
Risk factors  Obesity linked with high calorie 
intake. Hypertension 
Complications  DM patients showed: Higher 
mortality rate; Blindness more 
common; Acute MI more 
common; Left Ventricular 
failure more common; 
Neuropathy in lower limbs more 
T2DM 
prevalence 
 7.7% (5.9% previously know, 
1.8% newly diagnosed) 
Newly 
Diagnosed 
T2DM 
 1.8% 
IGT  5.6% 
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A recent survey conducted on the attitudes and 
habits of Malta’s general practitioners (GPs) reported 
that there is a lack of consistency in their diabetic 
preventative and management practices. The screening 
methods used by GPs studied were varied, with a large 
percentage using capillary blood glucose as the 
screening test for diabetes. A correlation was found 
between the different generations of GPs and the 
screening tests used. Thus, older GPs (21years+ since 
graduation) tended to use the HbA1C test more as a 
screening method when compared to younger GPs.21  
 
Diabetes action plan 
With the recent establishment of a governmental 
diabetes focus group and the first national diabetes plan 
being in the pipeline, the time is right to update the 
situation on the prevalence of diabetes type 2 and stop 
basing pharmacological and therapeutic plans on 
estimates of prevalence that are now no longer viable 
due to the time and changes in the population in terms of 
aging and changing risk factor profiles. 22 
A prevalence study at this point in time would be an 
opportunity to look at current generation of Maltese and 
their changing determinants and diabetes risk factors. 
Among these are the growing problems of obesity, the 
earlier onset of insulin resistance as seen globally.2 It is 
also an opportunity to engage hitherto unavailable 
technology to study the underlying genetic 
predisposition among the Maltese population.  
It is also a critical point in which to study the 
Maltese pre-diabetic population by linking prevalence to 
predisposition and risk factors - which may ultimately 
lead to eventual type 2 diabetes. Acquiring knowledge 
on the local precursor situation of diabetes (pre-diabetes) 
among a representative sample of adult Maltese today 
would be of great public health importance. Such a 
cross-sectional prevalence study has been proposed and 
is set to start at the end of 2014.23 This epidemiological 
study aims to study a representative 1% of the adult 
Maltese population. The aim is to come up with valid 
and reliable updated diabetes type 2 prevalence figures 
as well as to have the first obesity, hypertension, 
smoking and alcohol consumption prevalence study with 
the power to give reliable figures. It is also set to 
understand the current Maltese dietary lifestyle and 
identify the risk factors predisposing the Maltese 
population to pre-diabetes and diabetes. This data can in 
turn be used to establish a diabetes risk score by age, 
gender and other factors for persons living in Malta.  
With reliable updated diabetes prevalence figures as 
well as the establishment of the frequency of Diabetes 
risk factors in the Maltese Islands, a prevention strategy, 
a Diabetes policy and achievable population targets can 
then be accurately established to enable an evidence 
basis for Diabetes control plans.  
Of the two broad strategies for the prevention of 
any disease –high risk and population strategies, none 
can yet be said to be underway in the Maltese Islands, 
historical hub of Diabetes in the Mediterranean. Both 
can, however, be employed side by side. 
Employing the high-risk strategy for which 
screening is essential would enable the identification of 
high-risk individuals so that early action can be taken for 
them and ensure effective therapy.  On the positive side, 
this tends to be an acceptable way forward for patients 
and health professionals while efficiently reducing 
disease and risk. The negative side is that this is not 
really a radically effective prevention strategy and is 
more geared at secondary prevention. The 1968 Wilson 
and Jungner criteria, universally accepted for any 
screening programme, are all satisfied in the case of 
Diabetes and its impact on the Maltese population: 
Diabetes is an important disease; there is an acceptable 
and an effective screening tool which can be performed 
regularly - one which is acceptable to patients and health 
professionals alike; there is a recognizable early 
detectable stage and the natural history of the disease is 
well known; there exist facilities to bring about effective 
investigation and control of the disease and the costs 
should be balanced relative to other health costs.25 
The other option - the population strategy, involves 
the broad action needed to prevent the primary causes of 
the disease (lack of exercise, poor diet, obesity) for all 
individuals in the Maltese population, irrespective of 
their current risk status. This would involve a multi-
sectoral approach including targeted taxation, aimed this 
time at high fat, high calorie foods and coupled with 
initiatives in the environment.  It would also involve 
influencing the access to a healthier lifestyle - 
restrictions on importation and on the food 
manufacturing industry, an educational drive and action 
in other related areas for a concerted action. 24  
Given the sustained negative impact of Diabetes on 
health and the prospect of an ever greater impact of the 
disease on the lives of adults in Malta with each passing 
year, there is no reason why both strategies should not 
be initiated and combined for the prevention and control 
of Diabetes in the coming years 
 
Conclusion 
Diabetes Mellitus type 2 has been a sustained health 
burden among the Maltese population probably for a 
long time, but certainly, over the past century with more 
accurate measures gauging the problem in the 1960s and 
1980s.  Over the last 33 years estimates were used to 
gauge the diabetes burden in Malta. Today, we do not 
really know how many diabetics and pre-diabetics reside 
in the Maltese islands and whether their needs are being 
largely met. A national plan and an accurate age-gender 
disease profile are essential for the planning of control 
measures for Diabetes among adults in Malta, especially 
given the high impact of this disease locally.  
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A proposed diabetes prevalence study now getting 
underway aims to provide the evidence basis for updated 
health policies and to furnish health care workers with 
validated information about this disease. 
Establishing profiles of the different risk groups 
(for pre-diabetes and diabetes) and their associated 
anthropometric, biochemical markers and genetic factors 
is another achievable key goal.  
Preventive strategies can combine the benefits of 
screening high-risk controls with pan-population 
initiatives; bring healthy food and regular exercise 
within easier access of every Maltese.26  
The development of a predictive tool such as an 
“app” for mobile phones and computers could help 
individuals measure their risk of developing or having a 
disease such as diabetes. This could be incorporated into 
primary care practice by patients, health insurers and 
health professionals. Identifying those in the population 
with highest predisposing pre-diabetes risk factors and 
formulating a pre-diabetic risk score would help pick up 
susceptible subjects at an early stage. Such risk scores 
reduce the cost and inconvenience of unnecessary 
screening.27  
This information, placed within a national diabetes 
plan, would enable the Maltese health services to be 
better equipped to come to grips with this ever growing 
epidemic while aiding to improve the quality of life of 
those affected by the disease.  
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